From: Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Peptide | Position | HLA class-I alleles | Vaxijen score |
---|---|---|---|
LSPRWYFYY | 104–112 | HLA-A*0101, HLA-A*3002, HLA-B*5701, HLA-A*1101, HLA-A*2601, HLA-B*5801, HLA-A*2402, HLA-A*3101, HLA-B*3501, HLA-B*1501, HLA-A*0301, HLA-A*6801 | 1.2832 |
RSRNSSRNS | 189–197 | HLA-A*3001 | 1.1144 |
IGYYRRATR | 84–92 | HLA-A*3101, HLA-A*3301, HLA-A*6801, HLA-A*0301, HLA-A*3001 | 0.8880 |
FTALTQHGK | 53–61 | HLA-A*6801, HLA-A*1101, HLA-A*0301, HLA-A*0101, HLA-A*3001, HLA-A*3101 | 0.8510 |
KSAAEASKK | 249–257 | HLA-A*0301, HLA-A*1101, HLA-A*3001, HLA-A*6801, HLA-A*3101 | 0.7679 |
FPRGQGVPI | 66–74 | HLA-B*0702, HLA-B*5101, HLA-B*5301, HLA-B*0801, HLA-B*3501 | 0.7585 |